Pfizer Laboratories, AHFS Product Form, August 23, 1976.
3.
ConstantineJ. W.: Analysis of the Hypotensive Action of Prazosin, in Prazosin—Evaluation of A New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 16–36, 1974.
4.
HessH. J.: Biochemistry and Structure — Activity Studies With Prazosin, in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 3–15, 1974.
5.
Kincaid-SmithP.: Prazosin and Hydralazine in the Treatment of Hypertension, Clin. Sci. Mol. Med.51: 617s–619s, 1976.
GuevaraJ.: Antihypertensive Effect of Prazosin Alone and Its Combination With Polythiazide in Patients With Essential Hypertension, Curr. Ther. Res.20: 751–756 (Dec.) 1976.
8.
RougierM.: Prazosin—A New Antihypertensive Agent, Br. J. Clin. Pract.28: 280–284 (Aug.) 1974.
9.
WeberM. A.StokesG. S.: Treatment of Hypertension With an Antihypertensive Agent Possessing Vasodilator Activity, Med. J. Aust.1 (suppl): 9–11, 1975.
10.
BradleyW. F.: Comparison of Prazosin and Methyldopa in Mild to Moderate Hypertension, A Multicenter Cooperative Study, Curr. Ther. Res.21: 28–35 (Jan.) 1977.
11.
SchnaperH. W.ObermanA.: Double-Blind Studies of the Clinical Effectiveness of Prazosin, Prazosin Clinical Symposium Proceedings, Postgrad. Med.: 81–87 (Nov.) 1975.
12.
MroczekW. J.: Prazosin in Hypertension: A Double-Blind Evaluation with Methyldopa and Placebo, Curr. Ther. Res.16: 769–777 (Aug.) 1974.
13.
BloomD. S.: Clinical Evaluation of Prazosin as the Sole Agent for the Treatment of Hypertension: A Double-Blind Cross-Over Study With Methyldopa, Curr. Ther. Res. (Sect. 2)18: 144–150 (July) 1975.
14.
HuaA. S. P.: Studies and Prazosin—A New Effective Hypotensive Agent. I, Med. J. Aust.1: 559–561 (Apr. 17) 1976.
WoodA. J.: Prazosin in Normal Subjects: Plasma Levels, Blood Pressure and Heart Rate, Br. J. Clin. Pharmacol.3: 199–201, 1976.
17.
OkunR.: Dosage Schedule Routine for Prazosin: Two Cross-Over Trials Comparing t.i.d. With q.i.d. Administration and t.i.d. With b.i.d. Administration, in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 82–91, 1974.
18.
SeedatY. K.: Prazosin in the Treatment of Hypertension, S. Afr. Med. J.49: 1741–1743 (Oct. 4) 1975.
19.
KoshyM. C.: Physiologic Evaluation of a New Anti-Hypertensive Agent: Prazosin HCl, Circulation55: 533–537 (Mar.) 1977.
20.
HayesJ. M.: Experience With Prazosin in the Treatment of Patients With Severe Hypertension, Med. J. Aust.1: 562–564 (Apr. 17) 1976.
21.
MasoniA.: Hemodynamic Study in Men of Medium-Term Treatment With a New Amino-Quinazoline Antihypertensive Agent (Prazosin), in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 54–63, 1974.
22.
MaxwellM. H.: Effects of Prazosin on Renal Failure and Fluid-Electrolyte Metabolism, Prazosin Clinical Symposium Proceedings, Postgrad. Med.: 36–41 (Nov.) 1975.
23.
BailyR. R.: Prazosin in the Treatment of Patients with Hypertension and Renal Functional Impairment, N.Z. Med. J.84: 467–468 (Dec. 22) 1976.
24.
CurtisJ. R.BatemanF. J. A.: Use of Prazosin in Management of Hypertension in Patients With Chronic Renal Failure and in Renal Transplant Recipients, Br. Med. J.4: 432–434 (Nov. 22) 1975.
25.
PittsN. E.: The Clinical Evaluation of Prazosin Hydrochloride, A New Anti-Hypertensive Agent, in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 149–163, 1974.
26.
AmeryA.: Double Blind Cross-Over Study With a New Vasodilator-Prazosin-in the Treatment of Mild Hypertension, in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD.W.K. Ed., Excerpta Medica, Amsterdam, Nether-ands, p. 100–110, 1974.
27.
BolliP.SimpsonF. O.: A Preliminary Clinical Trial of Prazosin: A New Oral Antihypertensive Agent, N.Z. Med. J.79: 969–972 (May 22) 1974.
28.
Prazosin and Loss of Consciousness, Adverse Reaction Series No. 12. London, Committee on Safety of Medicines, 1975.
29.
BendallM. J.: Side Effects of Prazosin, Br. Med. J.2: 1131–1132 (Nov. 6) 1976.
BolliP.: Effects of Prazosin in Patients with Hypertension, Clin. Pharmacol. Ther.20: 138–141 (Aug.) 1976.
37.
FalaseA. O.: Lack of Effect of Low Doses of Prazosin in Hypertensive Nigerians, Curr. Ther. Res.19: 603–611 (June) 1976.
38.
PitkajarviT.: Antihypertensive Action of Drug Combination: Polythiazide, Prazosin and Tolamolol, Curr. Ther. Res.21: 169–176 (Feb.) 1977.
39.
BolliP.SimpsonF. O.: New Vasodilator Drugs for Hypertension, Br. Med. J.1: 637 (Mar. 30) 1974.
40.
OhM. S.: Treatment of Hypertension With a Combination of Prazosin and Polythiazide, Prazosin Clinical Symposium Proceedings, Postgrad. Med.: 77–87 (Nov.) 1975.
41.
StokesG. S.WeberM. A.: Prazosin: Preliminary Report and Comparative Studies with Other Antihypertensive Agents, Br. Med. J.2: 298–300 (May 11) 1974.
42.
VenablesT. L.DuffR. S.: A Comparative Trial of Prazosin and Methyldopa, in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 111–117, 1974.
43.
KellawayG. S. M.: Adverse Drug Reactions During Treatment of Hypertension, Symposium on Hypertension, Drugs11 (suppl. 1): 91–99, 1976.
44.
Lund-JohansenP.: Hemodynamic Changes at Rest and During Exercise in Long-Term Prazosin Therapy of Essential Hypertension, in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 43–53, 1974.
45.
ThulinT.: Multicenter Study of the Antihypertensive Effect of Prazosin Hydrochloride (Prazosin) on Mild and Moderate Hypertension, in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 126–137, 1974.
46.
BolliP.SimpsonF. O.: Experience With Prazosin in the Treatment of Hypertension, Prazosin Clinical Symposium Proceedings, Postgrad. Med.: 69–76 (Nov.) 1975.
47.
CohenB. M.: Prazosin Hydrochloride (CP-12, 299–1), An Oral Anti-Hypertensive Agent: Preliminary Clinical Observations in Ambulatory Patients, J. Clin. Pharmacol.10: 408–417 (Nov.-Dec.) 1970.
48.
KimJ. S.: A Study of the Use of Prazosin in Hypertensive Patients in Korea, Clin. Sci. Mol. Med.51: 613s–616s, 1976.
49.
KuokkanenK.MattolaM. J.: Demonstration of an Additive Antihypertensive Effect of Prazosin and Polythiazide in Out-Patients, Curr. Ther. Res.17: 431–436 (May) 1975.
50.
RabS. M.Shabinfarooqui: Prazosin in the Treatment of Hypertension, Br. J. Clin. Pract.29: 337–342 (Dec.) 1975.
51.
SmithI. S.: A Three-Phase Clinical Evaluation of Prazosin, Prazosin Clinical Symposium, Postgrad. Med.: 53–60 (Nov.) 1975.
52.
FernandesM.: Prazosin in the Treatment of Hypertension, Clin. Sci. Molec. Med.48 (suppl.): 1815–1845, 1975.
53.
Kincaid-SmithP.: A New Look at the Treatment of Severe Hypertension, Clin. Sci. Molec. Med.45 (suppl. 1): 75–87s, 1973.
54.
Kincaid-SmithP.: Vasodilators in the Treatment of Hypertension, Med. J. Aust.1 (suppl.): 7–9 (Jan. 4) 1975.
55.
Kincaid-SmithP.: Changing Concepts in the Management of Hypertension, Med. J. Aust.1: 327–332 (Mar. 15) 1975.
56.
AdriaensenH.VryensR.: Prazosin in the Treatment of Hypertension, Practitioner214: 268–273 (Feb.) 1975.
57.
BaileyR. R.: The Kidney and Antihypertensive Therapy, Symposium on Hypertension, Drugs11 (suppl. 1): 70–77, 1976.
58.
BolanzoK.: Prazosin, a New Quinazoline Derivative in the Treatment of Essential Hypertension, in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 143–148, 1974.
59.
BradleyW. F.: A Long-Term Clinical Trial of Prazosin, Clinical Symposium Proceedings, Postgrad. Med.: 95–99 (Nov.) 1975.
60.
CurtisJ. R.: Prazosin in Patients With Chronic Renal Failure, Br. Med. J.3: 742–743 (Sept. 21) 1974.
HuaA.Kincaid-SmithP.: Prazosin and Hydralazine in the Treatment of Hypertension, Br. Med. J.3: 804–805 (Sept. 28) 1974.
63.
MaherP. H.: Clinical Evaluation of Prazosin in 20 Private Practice Patients, Prazosin Clinical Symposium Proceedings, Postgrad. Med.: 107–114 (Nov.) 1975.
64.
MeekD.: Acute Hypotension Following Treatment With Prazosin, Curr. Med. Res. Opin.3: 672–674, 1976.
65.
MoyerR. R.: Experience With Prazosin in a Clinical Setting, Prazosin Clinical Symposium Proceedings, Postgrad Med.: 101–106 (Nov.) 1975.
66.
OkunR.: Long-Term Efficacy and Safety of Prazosin in Essential Hypertension, Prazosin Clinical Symposium Proceedings, Postgrad. Med.: 67 (Nov.) 1975.
67.
OnestiG.: Prazosin in the Treatment of Hypertension, Clin. Pharmacol. Then15: 216 (Feb.) 1974.
68.
PaulR. R.: A Phase n Study of Prazosin Hydrochloride in Hypertensive Subjects, Int. J. Clin. Pharmacol. Biopharm.14: 271–274, 1976.
69.
RasmussenK.JensenH. A.: Prazosin In Treatment of Hypertension, Br. Med. J.4: 346 (Nov. 8) 1975.
70.
RasmussenK.JensenH. Ae.: A Cross-Over Study Between Hydralazine and Prazosin, Clin. Sci. Mol. Med.51: 621s–623s, 1976.
71.
SafarM. E.: Short-Term Hemodynamic Studies With Prazosin, in Prazosin—Evaluation of a New Anti-Hypertensive Agent, CottonD. W. K. Ed., Excerpta Medica, Amsterdam, Netherlands, p. 64–70, 1974.
72.
SeedatY. K.: Prazosin in Treatment of Hypertension, Br. Med. J.3: 305 (Aug. 2) 1975.
73.
ThienT.: Orthostatic Hypotension Due to Prazosin, Lancet1: 363 (Feb. 12) 1977.
74.
TurnerA. S.: Clinical Experience with Prazosin Hydrochloride in Arterial Hypotension, N.Z. Med. J.81: 240–242 (Mar. 12) 1975.
75.
TurnerA. S.: Clinical Experience with Prazosin in Hypertension, Prazosin Clinical Symposium Proceedings, Postgrad. Med.: 88–92 (Nov.) 1975.